Suppr超能文献

亚急性梗死患者中高强度急性再灌注标志物信号的临床意义

The Clinical Significance of the Hyperintense Acute Reperfusion Marker Sign in Subacute Infarction Patients.

作者信息

Lee Ji Young, Lee Kyung Mi, Kim Hyug-Gi, Woo Ho-Geol, Lee Jin San, Kim Eui Jong

机构信息

Department of Medicine, Graduate School, Kyung Hee University, #23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea.

Department of Radiology, College of Medicine, Kyung Hee University Hospital, Kyung Hee University, #23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea.

出版信息

Diagnostics (Basel). 2021 Nov 22;11(11):2161. doi: 10.3390/diagnostics11112161.

Abstract

PURPOSE

The hyperintense acute reperfusion marker (HARM) is characterized by the delayed enhancement of the subarachnoid or subpial space observed on postcontrast fluid-attenuated inversion recovery (FLAIR) images, and is considered a cerebral reperfusion marker for various brain disorders, including infarction. In this study, we evaluated the cerebral distribution patterns of HARM for discriminating between an enhancing subacute infarction and an enhancing mass located in the cortex and subcortical white matter.

MATERIALS AND METHODS

We analyzed consecutive patients who experienced a subacute ischemic stroke, were hospitalized, and underwent conventional brain magnetic resonance imaging including postcontrast FLAIR within 14 days from symptom onset, as well as those who had lesions corresponding to a clinical sign detected by diffusion-weighted imaging and postcontrast T1-weighted imaging between May 2019 and May 2021. A total of 199 patients were included in the study. Of them, 94 were finally included in the subacute infarction group. During the same period, 76 enhancing masses located in the cortex or subcortical white matter, which were subcategorized as metastasis, malignant glioma, and lymphoma, were analyzed. We analyzed the overall incidence of HARM in subacute ischemic stroke cases, and compared the enhancement patterns between cortical infarctions and cortical masses.

RESULTS

Among 94 patients with subacute stroke, 78 patients (83%) presented HARM, and among 76 patients with subcortical masses, 48 patients (63%) presented peripheral rim enhancement. Of 170 subcortical enhancing lesions, 88 (51.8%) showed HARM, and 78 (88.6%) were determined to be subacute infarction. Among 94 patients with subacute stroke, 48 patients (51%) had diffusion restrictions, and HARM was found in 39 patients (81.2%). Of the 46 patients (49%) without diffusion restriction, 39 patients (84.8%) showed HARM.

CONCLUSIONS

The presence of HARM was significantly associated with subacute infarctions. For the masses, a peripheral rim enhancement pattern was observed around the mass rather than the cerebral sulci on postcontrast FLAIR.

摘要

目的

高强度急性再灌注标志物(HARM)的特征是在对比剂增强液体衰减反转恢复(FLAIR)图像上观察到蛛网膜下腔或软脑膜下间隙延迟强化,被认为是包括梗死在内的各种脑部疾病的脑再灌注标志物。在本研究中,我们评估了HARM在脑内的分布模式,以鉴别皮层下急性梗死灶与位于皮层及皮层下白质的强化肿块。

材料与方法

我们分析了连续的亚急性缺血性卒中患者,这些患者均住院治疗,且在症状发作后14天内接受了包括对比剂增强FLAIR序列在内的常规脑磁共振成像检查,同时分析了2019年5月至2021年5月期间那些在扩散加权成像和对比剂增强T1加权成像上有与临床体征相符病变的患者。本研究共纳入199例患者。其中,94例最终纳入亚急性梗死组。同期,分析了76个位于皮层或皮层下白质的强化肿块,这些肿块被进一步分类为转移瘤、恶性胶质瘤和淋巴瘤。我们分析了亚急性缺血性卒中病例中HARM的总体发生率,并比较了皮层梗死灶与皮层肿块的强化模式。

结果

在94例亚急性卒中患者中,78例(83%)出现HARM;在76例皮层下肿块患者中,48例(63%)出现周边环形强化。在170个皮层下强化病灶中,88个(51.8%)出现HARM,其中78个(88.6%)被判定为亚急性梗死。在94例亚急性卒中患者中,48例(51%)有扩散受限,其中39例(81.2%)发现有HARM。在46例(49%)无扩散受限的患者中,39例(84.8%)出现HARM。

结论

HARM的存在与亚急性梗死显著相关。对于肿块,在对比剂增强FLAIR图像上,肿块周围而非脑沟周围观察到周边环形强化模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e26/8625489/5d6a51f38740/diagnostics-11-02161-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验